Both receptors recognize CD155 (also known as PVR) and CD112 (also known as Nectin-2), ubiquitous cell-adhesion molecules (167) overexpressed in HER2+ breast cancer cell lines (51). This evidence concerns the gene NECTIN2 and breast carcinoma.